Non Animal Testing Database
EnglischDeutsch

3D Glioblastoma ex vivo

Company
Neuron-D GmbH, Dresden, Germany
Glioblastoma multiforme (GBM) is the most common malignant brain tumor among adult patients and is almost universally fatal. Despite the recent leaps in knowledge about the genome, epigenome, and transcriptome of GBM, clinical outcomes in GBM have not changed over the years. To investigate this disease the company Neuron D has developed a 3D cell culture drug testing platform for glioblastoma multiforme (GBM). The 3D platform is based on the 3D starPEG-Heparin hydrogel technology. It enables drug developers to test the efficacy, safety and pharmacokinetics of candidate compounds for GBM in a three-dimensional, physiologically relevant tumor environment.
3D Glioblastoma ex vivo
www.neurond.de
#1619
Added on: 11-21-2022
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!